The treatment of prostatic carcinoma, the second commonest carcinoma in the Western world, remains controversial although opinion has leaned towards oestrogens rather than orchiectomy unless the patient suffers a thrombo-embolic tendency. 
The treatment of prostatic carcinoma, the second commonest carcinoma in the Western world, remains controversial although opinion has leaned towards oestrogens rather than orchiectomy unless the patient suffers a thrombo-embolic tendency. [9] [10] We report here a retrospective study of two statistically comparable groups (Table 2) .
Of the 106 patients treated by orchiectomy three quarters were still alive; of these 87 were treated more than 5 years previously and of them 52 were still alive giving a 60% 5-year survival rate.
Of the total of 83 patients in the two groups who ORCHIECT. m STILBOEST. (Table 3) . (Table 4) ; this was in contrast to those treated by orchiectomy, the majority of whom suffered flushes, but none of them had been treated for hypertension and two only had mild gynaecomastia (Table 4) . 
